EMCN and neoplasm: Importantly, immunostaining of a day 13 primary tumor for endosialin and the endothelial marker endomucin revealed endosialin+ stromal cells throughout the tumor bed closely associated with the vasculature (figure 3A), indicating that the E3K CAR-T cell target is well expressed in developing tumors.